Seres Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| FLAGSHIP PIONEERING INC. | 11/14/2025 | 1.16 M | $22.24 M | 0.00% | 13.22% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 316.30 K | $6.09 M | 280.17% | 3.62% |
| VANGUARD GROUP INC | 11/07/2025 | 311.89 K | $6.00 M | 6.78% | 3.57% |
| MARSHALL WACE, LLP | 11/13/2025 | 125.60 K | $2.42 M | 37.41% | 1.44% |
| HAP TRADING, LLC | 11/12/2025 | 125.00 K | $334.75 M | 100.00% | 1.43% |
| HUDSON BAY CAPITAL MANAGEMENT LP | 11/13/2025 | 125.00 K | $2.41 M | 100.00% | 1.43% |
| BLACKROCK, INC. | 11/12/2025 | 102.06 K | $1.96 M | 0.70% | 1.17% |
| VONTOBEL HOLDING LTD. | 10/15/2025 | 98.51 K | $1.90 M | 22.64% | 1.13% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 84.98 K | $1.64 M | -7.23% | 0.97% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 76.60 K | $1.47 M | 342.77% | 0.88% |
| CAPTION MANAGEMENT, LLC | 11/14/2025 | 75.00 K | $1.44 M | 100.00% | 0.86% |
| JANE STREET GROUP, LLC | 11/14/2025 | 68.10 K | $1.31 M | 100.00% | 0.78% |
| J. GOLDMAN & CO LP | 11/14/2025 | 61.90 K | $1.19 M | 100.00% | 0.71% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/10/2025 | 31.40 K | $604.19 K | -9.96% | 0.36% |
| CITADEL ADVISORS LLC | 11/14/2025 | 30.89 K | $594.23 K | 100.00% | 0.35% |
| CITADEL ADVISORS LLC | 11/14/2025 | 30.01 K | $577.39 K | 179.94% | 0.34% |
| STATE STREET CORP | 11/14/2025 | 29.73 K | $572.02 K | 10.81% | 0.34% |
| SCHONFELD STRATEGIC ADVISORS LLC | 11/14/2025 | 28.94 K | $556.84 K | 100.00% | 0.33% |
| LION POINT CAPITAL, LP | 11/14/2025 | 27.14 K | $522.14 K | 59.28% | 0.31% |
| J. GOLDMAN & CO LP | 11/14/2025 | 27.00 K | $519.48 K | 100.00% | 0.31% |
| CENTIVA CAPITAL, LP | 11/14/2025 | 25.00 K | $481.00 K | 100.00% | 0.29% |
| CITADEL ADVISORS LLC | 11/14/2025 | 24.33 K | $468.11 K | 100.00% | 0.28% |
| MORGAN STANLEY | 11/14/2025 | 18.33 K | $352.75 K | 133.91% | 0.21% |
| UBS GROUP AG | 11/13/2025 | 12.68 K | $244.00 K | 68.37% | 0.15% |
| NORTHERN TRUST CORP | 11/14/2025 | 12.10 K | $232.82 K | -19.73% | 0.14% |
| BELVEDERE TRADING LLC | 10/27/2025 | 12.10 K | $232.80 K | 100.00% | 0.14% |
| INVESCO LTD. | 11/13/2025 | 10.44 K | $200.90 K | 100.00% | 0.12% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 5.34 K | $102.80 K | 2,772.58% | 0.06% |
| SBI SECURITIES CO., LTD. | 11/05/2025 | 3.48 K | $66.99 K | 0.00% | 0.04% |
| SIMPLEX TRADING, LLC | 11/12/2025 | 2.81 K | $54.00 K | 100.00% | 0.03% |
| CITIGROUP INC | 11/10/2025 | 2.62 K | $50.43 K | 29,022.22% | 0.03% |
| FMR LLC | 11/13/2025 | 1.88 K | $36.21 K | -99.30% | 0.02% |
| BARCLAYS PLC | 11/12/2025 | 1.41 K | $27.09 K | 100.00% | 0.02% |
| ROYAL BANK OF CANADA | 11/14/2025 | 296 | $6.00 K | -95.74% | 0.00% |
| BNP PARIBAS ARBITRAGE, SNC | 11/13/2025 | 212 | $4.08 K | -30.49% | 0.00% |
| PHYSICIAN WEALTH ADVISORS, INC. | 11/04/2025 | 142 | $2.73 K | 0.00% | 0.00% |
| BELVEDERE TRADING LLC | 10/27/2025 | 100 | $1.92 K | 100.00% | 0.00% |
| JPMORGAN CHASE & CO | 11/26/2025 | 65 | $1.25 K | 0.00% | 0.00% |
| US BANCORP \DE\ | 11/12/2025 | 12 | $231 | -52.00% | 0.00% |
| WELLS FARGO & COMPANY/MN | 11/13/2025 | 10 | $192 | 0.00% | 0.00% |
| SOUND INCOME STRATEGIES, LLC | 10/10/2025 | 8 | $156 | 100.00% | 0.00% |
| ADVISOR GROUP HOLDINGS, INC. | 11/14/2025 | 8 | $151 | 0.00% | 0.00% |
| FEDERATION DES CAISSES DESJARDINS DU QUEBEC | 11/14/2025 | 3 | $58 | 100.00% | 0.00% |
| SRS CAPITAL ADVISORS, INC. | 11/14/2025 | 2 | $38 | 100.00% | 0.00% |
| RAYMOND JAMES FINANCIAL INC | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| ATLANTIC UNION BANKSHARES CORP | 11/04/2025 | 0 | $0 | -100.00% | 0.00% |
| WOLVERINE TRADING, LLC | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| GROUP ONE TRADING, L.P. | 11/12/2025 | 0 | $0 | -100.00% | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| WHITTIER TRUST CO | 10/31/2025 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Seres Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 75 institutional investors and hedge funds held shares of Seres Therapeutics, Inc.. The most heavily invested institutionals were:
Flagship Pioneering Inc.: 1.16 M
VANGUARD GROUP INC: 311,889
MARSHALL WACE, LLP: 125,600
BlackRock, Inc.: 102,060
Vontobel Holding Ltd.: 98,511
GEODE CAPITAL MANAGEMENT, LLC: 84,982
24.31% of Seres Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 33.41 M shares in the last 24 months. This purchase volume represents approximately $598.05 M in transactions.